Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2018 2
2019 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
The Expanding Therapeutic Utility of Botulinum Neurotoxins.
Fonfria E, Maignel J, Lezmi S, Martin V, Splevins A, Shubber S, Kalinichev M, Foster K, Picaut P, Krupp J. Fonfria E, et al. Among authors: splevins a. Toxins (Basel). 2018 May 18;10(5):208. doi: 10.3390/toxins10050208. Toxins (Basel). 2018. PMID: 29783676 Free PMC article. Review.
Elucidation of critical pH-dependent structural changes in Botulinum Neurotoxin E.
Lalaurie CJ, Splevins A, Barata TS, Bunting KA, Higazi DR, Zloh M, Spiteri VA, Perkins SJ, Dalby PA. Lalaurie CJ, et al. Among authors: splevins a. J Struct Biol. 2022 Jun 20;214(3):107876. doi: 10.1016/j.jsb.2022.107876. Online ahead of print. J Struct Biol. 2022. PMID: 35738335 Free article.
Correction: Field, M. et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients.
Field M, Splevins A, Picaut P, van der Schans M, Langenberg J, Noort D, Snyder D, Foster K. Field M, et al. Among authors: splevins a. Toxins (Basel). 2019 Feb 13;11(2):115. doi: 10.3390/toxins11020115. Toxins (Basel). 2019. PMID: 30781899 Free PMC article.